Page last updated: 2024-08-21

oxazoles and navitoclax

oxazoles has been researched along with navitoclax in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akudugu, JM; Hamunyela, RH; Serafin, AM	1

Other Studies

1 other study(ies) available for oxazoles and navitoclax

Article	Year
Strong synergism between small molecule inhibitors of HER2, PI3K, mTOR and Bcl-2 in human breast cancer cells. Toxicology in vitro : an international journal published in association with BIBRA, 2017, Volume: 38 Topics: Aniline Compounds; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Synergism; Humans; Imidazoles; Oxazoles; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Quinolines; Receptor, ErbB-2; Sulfonamides; TOR Serine-Threonine Kinases; Triazoles	2017

Article

Year

Strong synergism between small molecule inhibitors of HER2, PI3K, mTOR and Bcl-2 in human breast cancer cells.

Toxicology in vitro : an international journal published in association with BIBRA, 2017, Volume: 38

Topics: Aniline Compounds; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Synergism; Humans; Imidazoles; Oxazoles; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Quinolines; Receptor, ErbB-2; Sulfonamides; TOR Serine-Threonine Kinases; Triazoles

2017